Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Forward Pharma ADR (FWP)

Forward Pharma ADR (FWP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 13,828
  • Shares Outstanding, K 7,091
  • Annual Sales, $ 0 K
  • Annual Income, $ -1,890 K
  • 60-Month Beta 1.38
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 0.22
Trade FWP with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm 0.00
  • Most Recent Earnings N/A on N/A
  • Latest Earnings Date 04/13/22
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend 23.073 on 09/12/17
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.5000 +30.00%
on 12/19/22
3.1900 -38.87%
on 12/06/22
-1.0500 (-35.00%)
since 11/25/22
3-Month
1.5000 +30.00%
on 12/19/22
3.3000 -40.91%
on 10/31/22
-1.0700 (-35.43%)
since 09/27/22
52-Week
1.5000 +30.00%
on 12/19/22
6.4800 -69.91%
on 01/06/22
-3.8900 (-66.61%)
since 12/27/21

Most Recent Stories

More News
Forward Pharma Reports Financial and Operating Results for the Year Ended December 31, 2021

COPENHAGEN, Denmark, April 08, 2022 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ:FWP) (“we,” “Forward” or the “Company” and, together with its...

FWP : 1.9500 (+7.73%)
Forward Pharma Announces the Decision of the Technical Board of Appeal of the European Patent Office in the EP2801355 Appeal Hearing

COPENHAGEN, Denmark, Sept. 06, 2021 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ:FWP) (“we,” “Forward” or the “Company”), today announced that the Technical Board of Appeal (the “TBA”)...

FWP : 1.9500 (+7.73%)
Forward Pharma Reports Financial and Operational Results from the Year Ended December 31, 2020

COPENHAGEN, Denmark, April 14, 2021 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ:FWP) (“We,” “Forward” or the “Company” and, together with its subsidiaries, the “Group”), today reported...

FWP : 1.9500 (+7.73%)
Forward Pharma Announces Rescheduling of the EP2801355 Appeal Hearing to September 6, 2021 due to COVID-19 Restrictions

COPENHAGEN, Denmark, Jan. 12, 2021 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ:FWP) (“we,” “Forward” or the “Company”), today announced that due to ongoing precautionary measures against...

FWP : 1.9500 (+7.73%)
Forward Pharma Announces New Date for the EP2801355 Appeal Hearing due to COVID-19

COPENHAGEN, Denmark, May 12, 2020 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ:FWP) (“we,” “Forward” or the “Company”), today announced that due to current precautionary measures against...

FWP : 1.9500 (+7.73%)
Forward Pharma Reports Financial and Operational Results from the Year Ended December 31, 2019

COPENHAGEN, Denmark, April 24, 2020 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ:FWP) (“We,” “Forward” or the “Company” and, together with its subsidiaries, the “Group”), today reported...

FWP : 1.9500 (+7.73%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Forward Pharma A/S is a biotechnology company. It is focused on the immunomodulatory compound dimethyl fumarate and derivatives, for applications as a pharmaceutical drug product to treat immune disorders such as multiple sclerosis and psoriasis. The Company is advancing its lead drug candidate FP187...

See More

Key Turning Points

3rd Resistance Point 2.1467
2nd Resistance Point 2.1033
1st Resistance Point 2.0267
Last Price 1.9500
1st Support Level 1.9067
2nd Support Level 1.8633
3rd Support Level 1.7867

See More

52-Week High 6.4800
Fibonacci 61.8% 4.5776
Fibonacci 50% 3.9900
Fibonacci 38.2% 3.4024
Last Price 1.9500
52-Week Low 1.5000

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar